ClinicalTrials.Veeva

Menu

Local Anesthetic for Plateau Fractures

University of Washington logo

University of Washington

Status and phase

Not yet enrolling
Phase 4

Conditions

Tibial Plateau Fractures

Treatments

Drug: Bupivacaine injection
Other: Saline

Study type

Interventional

Funder types

Other

Identifiers

NCT06474949
STUDY00017105

Details and patient eligibility

About

Subjects may receive an injection at the end of the surgery to fix their broken leg that may reduce their pain and hospital stay

Full description

Subjects will be randomized to bupivicaine or saline injection in the joint at the end of Open Reduction Internal Fixation of the tibial plateau fracture

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Age >=18 year ,
  • tibial plateau fracture undergoing Open Reduction and fixation"

Exclusion:

  • allergy to bupivacaine
  • Prolonged external fixator use

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

100 participants in 2 patient groups, including a placebo group

Bupivacaine
Active Comparator group
Description:
Bupivacaine
Treatment:
Drug: Bupivacaine injection
Saline
Placebo Comparator group
Description:
Saline
Treatment:
Other: Saline

Trial documents
1

Trial contacts and locations

0

Loading...

Central trial contact

Julie Agel

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems